|
PPP2R3C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.352200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.545400E-01 |
| Normal-vs-Stage2 |
9.185400E-01 |
| Normal-vs-Stage3 |
8.562200E-02 |
| Normal-vs-Stage4 |
1.547950E-01 |
| Stage1-vs-Stage2 |
8.202600E-01 |
| Stage1-vs-Stage3 |
9.056000E-02 |
| Stage1-vs-Stage4 |
1.611850E-01 |
| Stage2-vs-Stage3 |
1.624210E-01 |
| Stage2-vs-Stage4 |
2.202400E-01 |
| Stage3-vs-Stage4 |
9.634200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.669600E-01 |
| Normal-vs-AfricanAmerican |
3.881500E-02 |
| Normal-vs-Asian |
9.692600E-01 |
| Caucasian-vs-AfricanAmerican |
8.718400E-02 |
| Caucasian-vs-Asian |
8.769200E-01 |
| AfricanAmerican-vs-Asian |
3.812800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.069000E-01 |
| Normal-vs-Female |
3.424600E-01 |
| Male-vs-Female |
8.447200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.834200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.183600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.152800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.729000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.689800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.969200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.346800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.192200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.530800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.941200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.940400E-01 |
| Normal-vs-Grade 2 |
8.768000E-01 |
| Normal-vs-Grade 3 |
7.754000E-02 |
| Normal-vs-Grade 4 |
1.153970E-01 |
| Grade 1-vs-Grade 2 |
3.565000E-01 |
| Grade 1-vs-Grade 3 |
2.673600E-02 |
| Grade 1-vs-Grade 4 |
2.756200E-02 |
| Grade 2-vs-Grade 3 |
3.362300E-02 |
| Grade 2-vs-Grade 4 |
5.461800E-02 |
| Grade 3-vs-Grade 4 |
7.778400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.109600E-01 |
| Normal-vs-ccB subtype |
1.495960E-01 |
| ccA subtype-vs-ccB subtype |
3.689700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.577000E-01 |
| Normal-vs-N1 |
3.506200E-02 |
| N0-vs-N1 |
1.447770E-01 |
|
|
